- Home
- AGEN vs AIRT Comparison
AGEN vs AIRT Comparison
Compare AGEN & AIRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGEN
- AIRT
- Stock Information
- Founded
- AGEN 1994
- AIRT 1980
- Country
- AGEN United States
- AIRT United States
- Employees
- AGEN N/A
- AIRT N/A
- Industry
- AGEN Biotechnology: Biological Products (No Diagnostic Substances)
- AIRT Air Freight/Delivery Services
- Sector
- AGEN Health Care
- AIRT Consumer Discretionary
- Exchange
- AGEN Nasdaq
- AIRT Nasdaq
- Market Cap
- AGEN 38.1M
- AIRT 42.4M
- IPO Year
- AGEN 2000
- AIRT N/A
- Fundamental
- Price
- AGEN $3.16
- AIRT $16.60
- Analyst Decision
- AGEN Buy
- AIRT
- Analyst Count
- AGEN 4
- AIRT 0
- Target Price
- AGEN $8.00
- AIRT N/A
- AVG Volume (30 Days)
- AGEN 655.0K
- AIRT 3.0K
- Earning Date
- AGEN 05-06-2025
- AIRT 02-12-2025
- Dividend Yield
- AGEN N/A
- AIRT N/A
- EPS Growth
- AGEN N/A
- AIRT N/A
- EPS
- AGEN N/A
- AIRT N/A
- Revenue
- AGEN $103,463,000.00
- AIRT $298,215,000.00
- Revenue This Year
- AGEN $4.03
- AIRT N/A
- Revenue Next Year
- AGEN $5.57
- AIRT N/A
- P/E Ratio
- AGEN N/A
- AIRT N/A
- Revenue Growth
- AGEN N/A
- AIRT 3.36
- 52 Week Low
- AGEN $1.38
- AIRT $14.56
- 52 Week High
- AGEN $19.69
- AIRT $30.60
- Technical
- Relative Strength Index (RSI)
- AGEN 78.44
- AIRT 49.17
- Support Level
- AGEN $1.60
- AIRT $15.84
- Resistance Level
- AGEN $1.83
- AIRT $16.74
- Average True Range (ATR)
- AGEN 0.31
- AIRT 0.66
- MACD
- AGEN 0.21
- AIRT 0.15
- Stochastic Oscillator
- AGEN 97.52
- AIRT 62.96
About AGEN Agenus Inc.
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).
About AIRT Air T Inc.
Air T Inc together with its subsidiaries provides air freight service to the express delivery industry. The company's operating segments include Overnight air cargo, Ground equipment sales, Commercial jet engines, and parts, Corporate, and Others. The company generates maximum revenue from the Commercial Jet Engines and Parts segment.